VSee

What VSee does

VSee (NASDAQ: VSEE), operating through VSee Lab, Inc. and parent VSee Health, Inc., is a publicly traded telehealth platform that combines HIPAA-compliant video, configurable clinical workflows, remote patient monitoring, EHR integration, and a growing suite of AI capabilities. The product portfolio is built around a modular architecture: VSee Free, Plus ($29/provider/month) and Premium ($49/provider/month) self-serve tiers, an Enterprise white-label deployment tier with 250+ configuration points, VSee Messenger for secure group video, APIs/SDKs for developer integration, telemedicine carts and kits, and post-2025 AI modules including the VSee AI Doctor Notes (generative clinical documentation), VSee AI Robot (autonomous LiDAR-navigating hospital robot), and the AI Velocity / AI Workflow Engine integration fabric supporting 100+ clinical AI capabilities. The platform is deployed across 1000+ enterprises including LA County, Mass General, McKesson, GE Healthcare, Optum, the VA, Tampa General, and NASA, and processes roughly 1.5 million video encounters per month.

The business mixes software subscriptions with hardware sales and managed services. Enterprise revenue is generated through multi-year contracts with hospital systems and Integrated Delivery Networks, augmented by a $10 million multi-year teleradiology contract with a Level 1 hospital system and ongoing AI-Documentation, Virtual ICU (via DocBox), and prescription-fulfillment (via GoMyRx) partnerships. The go-to-market is hybrid: direct enterprise field sales for large health systems and federal buyers enabled by FedRAMP High authorization, paired with product-led growth via the Free tier that funnels solo practitioners into Plus and Premium plans. Reported revenue was $14.6 million in full-year 2025 (up approximately 40% from $10.4 million in 2024) with Q1 2026 revenue of $2.5 million (up 70% year-over-year), supported by a roughly $6 million private placement in November 2025 and $5.3 million of cash at year-end 2025.

The company is in the middle of a significant corporate transition. In May 2026 VSee Health divested the VSee Lab subsidiary to former Co-CEO and Chairman Milton Chen, retiring approximately 7% of outstanding shares, reducing roughly $6 million in annual operating expenses, and consolidating focus on the iDoc enterprise telehealth platform under sole CEO Dr. Imoigele Aisiku. The strategic emphasis is shifting toward AI-driven clinical workflows, autonomous robotics, Virtual ICU offerings, and federal healthcare expansion, even as the equity has experienced a sharp price decline from $12.20 in 2024 to $0.24 in 2026.

Name

VSee

Legal name

VSee Lab, Inc.

Website

https://vsee.com

Company type

Public

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

VSee (NASDAQ: VSEE) is a publicly traded telehealth platform offering HIPAA-compliant video, configurable clinical workflows, remote patient monitoring, and AI modules including an autonomous hospital robot and AI clinical documentation, serving hospitals, IDNs, federal healthcare, and individual providers.

Ownership category

akta.pro rank

Product category

Telehealth Platform Software

NAICS

Offices of Physicians (6211)

SIC

Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Virtual Visit & Scheduling Platforms (EHR-integrated) (HLALABAA)

akta.pro secondary industries

Virtual Visit & Video Conferencing APIs/SDKs (HIPAA-compliant) (HLALAKAA), Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)

Keywords

• HIPAA-compliant telemedicine
• Telehealth platform software
• Remote patient monitoring
• AI clinical documentation
• Virtual care workflows

Headquarters

HQ city

San Jose

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SaaS Platform Subscriptions: Subscription-based revenue from VSee Clinic platform tiers (Free, Plus at $29/month, Premium at $49/month, and Enterprise custom pricing). Per-provider pricing for Premium and Enterprise. Monthly subscriptions are month-to-month; Enterprise typically requires annual subscription.
2. Hardware Sales: Sale of telemedicine carts, kits, and medical devices including stethoscopes, otoscopes, dermatoscopes, ultrasound, EKG devices compatible with the platform.
3. Teleradiology Contracts: Multi-year teleradiology service contracts with hospital systems. Disclosed $10 million multi-year teleradiology contract with a Level 1 hospital system.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

VSee sells a HIPAA-compliant telehealth platform that combines secure video visits, AI-powered clinical documentation, remote patient monitoring, EHR integrations, and the VSee AI Robot — an autonomous LiDAR-navigated telehealth robot for hospital deployment. The offering spans self-serve subscriptions for solo practitioners (Free, Plus, Premium tiers) and enterprise white-label deployments with multi-year contracts for health systems, IDNs, and federal healthcare customers.

Product overview

VSee offers a modular telehealth platform architecture combining core video consultation software with specialized add-on modules and hardware products. The platform consists of VSee Enterprise (white-label telehealth), VSee Messenger (secure video/messaging), VSee APIs & SDKs (developer tools), and VSee Remote Patient Monitoring, augmented by AI capabilities including the VSee AI Robot (autonomous hospital robot), AI Doctor Notes (clinical documentation), and AI Workflow Engine/Velocity (AI integration fabric). Hardware offerings include telemedicine carts and kits. The platform serves healthcare enterprises with HIPAA-compliant video visits, scheduling, queuing, EHR integration (Epic, Cerner, NextGen, Credible), and payment processing via Stripe, with FedRAMP High authorization enabling federal healthcare deployments. Recent strategic focus includes autonomous telehealth robotics, AI-powered documentation, and Virtual ICU solutions.

Differentiator

Problem solved

Functional benefit

Brands

• VSee AI Robot: World's first fully autonomous telehealth AI robot purpose-built for hospital deployment, capable of navigating hospital corridors using LiDAR to reach patient bedsides independently.
• VSee AI Doctor Notes
• VSee AI Workflow Engine
• VSee Clinic
• VSee Messenger
• VSee Free
• VSee Enterprise

Products and services

• VSee Enterprise White-label telehealth platform with 250+ configuration points, branded mobile app, custom workflows, SSO/MFA, and EHR integrations for enterprise health systems and IDNs.
• VSee Free Free HIPAA-compliant video, voice, and chat platform with no download required, unlimited 1-1 HD video calls, and signed BAA for HIPAA compliance.
• VSee Plus Solo practitioner subscription at $29/month per provider adding patient portal, scheduling, intake forms, SMS/email reminders, and credit card payments.
• VSee Premium Team-tier subscription at $49/month per provider with shared waiting room, shared scheduling, custom intake forms, standard EMR notes, and analytics.
• VSee APIs and SDKs Pre-built telehealth modules and JavaScript SDKs for developers to create branded patient mobile and web apps with self-serve tools for patient engagement, video visits, queuing, and scheduling.
• VSee Remote Patient Monitoring RPM platform supporting Bluetooth and cellular medical devices without app pairing, with customizable threshold alerts, auto-prioritized watchlists, and Medicare-compliant data capture.
• VSee AI Robot World's first fully autonomous telehealth AI robot for hospital deployment using LiDAR navigation to reach patient bedsides without staff assistance, enabling virtual physician rounding, telestroke response, medication delivery, and patient triage.
• VSee AI Doctor Notes AI-powered clinical documentation tool that transcribes patient visits and generates billable notes in custom formats (SOAP, DAP, BIRP) with ICD/CPT code generation, achieving 93% documentation time reduction.
• VSee Messenger HIPAA-compliant secure group video, screenshare, and messaging app with stethoscope mode for telemedicine auscultation and mobile waiting room alerts.
• VSee Telemedicine Carts and Kits Hardware solutions including telemedicine carts and kits for point-of-care video consultations, supporting medical devices such as stethoscopes, otoscopes, dermatoscopes, ultrasound, and EKG.
• VSee Teleradiology Teleradiology services for reading and interpretation of medical imaging under multi-year contracts with hospital systems.
• iDoc Telehealth Platform Enterprise telehealth platform acquired by VSee Health, providing AI-powered telehealth solutions and autonomous hospital robot platform capabilities.

Quantifiable outcome

• 93% reduction in clinical documentation time (from 10-15 minutes to under 1 minute) for Tele911 emergency medicine providers
• +7 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability10 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core and flagship.

• GoMyRxcoreStrategic or Co-development Partner · 5 February 2026Strategic managed services partnership to integrate digital prescription fulfillment into VSee Health's telehealth infrastructure. GoMyRx, an affiliate of GoMyDocs, serves as VSee Health's primary operational integration partner for prescription workflow coordination and medication fulfillment. The partnership combines VSee's virtual care technology with GoMyRx's fulfillment operations and GoMyDocs' pharmaceutical compounding and logistics network to expand digital healthcare delivery capabilities nationwide.
• DocBoxflagshipStrategic or Co-development Partner · 29 January 2026Strategic partnership to launch the first augmented intelligence platform for a Virtual ICU. The platform aims to create a scalable, AI-native Virtual ICU that enhances enterprise value and generates recurring revenue. Combines VSee's telehealth platform with DocBox's critical care technology.
• Health Tech Without BordersflagshipStrategic or Co-development Partner · 1 January 2023Selected by Health Tech Without Borders global nonprofit for health equity as technology partner for its 2023 Clinton Global Initiative Commitment to Action (VITAL Africa project in Cameroon). VSee provides telehealth technology platform for healthcare equity initiatives in Africa.

Scale indicators8 records

Recent moves10 records

Expansion highlights7 records

Broad incumbents

• Teladoc Health: Largest publicly traded virtual care platform in the US, offering enterprise telehealth, chronic condition management, and virtual primary care. Comparable as a multi-vertical telehealth incumbent competing for the same health system and payer RFPs that VSee targets.
• Zoom (Zoom Healthcare): Generic video conferencing platform with HIPAA-compliant Zoom for Healthcare, used by many providers for virtual visits. Comparable as a lower-cost alternative and indirect competitor in the same telehealth video visit category.
• Microsoft Teams (Microsoft Cloud for Healthcare): Enterprise collaboration suite with healthcare workflow extensions, Teams EHR integrations, and Microsoft Cloud for Healthcare. Comparable as a broad incumbent platform competing for virtual visit and care collaboration workloads inside large health systems.

Direct peers

• Amwell: Enterprise telehealth platform with Converge platform, deep health system and payer integrations, and a hardware partner (TytoCare). Closely comparable to VSee in selling virtual visit infrastructure to health systems, IDNs, and payers.
• Doximity: Telehealth platform primarily serving US physicians with video visits, scheduling, and a dialer. Comparable as a SaaS telehealth workflow tool used by individual providers and large medical groups, with overlapping self-serve and enterprise motions.
• Caregility: Enterprise telehealth platform focused on inpatient virtual care, tele-ICU, and clinical workflow. Directly comparable to VSee's hospital system and ICU use cases, including its DocBox partnership and telestroke/virtual rounding offerings.
• eVisit: Enterprise telehealth platform for hospitals and health systems with workflow, scheduling, and EHR integration. Comparable to VSee Enterprise in targeting IDN and health system deals with configurable virtual care workflows.
• TytoCare: Telehealth hardware and remote examination platform (TytoHome, TytoPro). Comparable to VSee's telemedicine carts/kits and integrated medical peripherals (stethoscopes, otoscopes) for remote exam workflows.

Regional players

• Hims & Hers Health: Direct-to-consumer virtual care platform focused on telehealth prescribing and asynchronous care. Comparable as a D2C telehealth operator with overlapping subscription-based virtual care economics, though anchored in consumer rather than enterprise channel.

Emerging players

• SOC Telemed (acquired by Patient Square Capital): Specialty telemedicine provider (tele-ICU, tele-stroke, tele-psychiatry) for hospital systems. Comparable to VSee's virtual specialty care use cases (telestroke, virtual ICU via DocBox) and similar IDN/hospital customer profile.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/VSee
• YouTubeyoutube.com/user/VSee2
• Facebookfacebook.com/vseelab
• LinkedInlinkedin.com/company/vsee

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds5 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VSee